CAS No.: 396091-77-3
Pasireotide L-aspartate salt/帕瑞肽天门冬氨酸盐 Catalog No. CSN18258
Synonyms: SOM230 L-aspartate;Pasireotide L-Aspartate Salt;帕瑞肽天门冬氨酸盐
Pasireotide L-aspartate is a stable cyclohexapeptide somatostatin mimic that exhibits unique high-affinity binding to human somatostatin receptors (subtypes sst1/2/3/4/5, pKi=8.2/9.0/9.1/< 7.0/9.9 respectively).
| 规格 | 价格 | 促销价格 | 库存 | 数量 |
|---|
400-920-2911
sales@csnpharm.cn
tech@csnpharm.cn
纯度 & 质量文件
批次:
靶点选择性
生物活性
- 描述
- 临床研究
NCT号 适应症或疾病 临床期 招募状态 预计完成时间 地点 NCT02780882 Ectopic ACTH Syndrome Phase 2 Withdrawn(Due to stringent inc... more >>lusion/exclusion criteria, study investigator deemed it not feasible.) Collapse << June 2019 United States, California ... more >> Cedars-Sinai Medical Center Los Angeles, California, United States, 90048 Collapse << - 参考文献
- [1] Quinn TJ, Yuan Z, et al. Pasireotide (SOM230) is effective for the treatment of pancreatic neuroendocrine tumors (PNETs) in a multiple endocrine neoplasia type 1 (MEN1) conditional knockout mouse model. Surgery. 2012 Dec;152(6):1068-77.
- [2] Murray RD, Kim K, et al. The novel somatostatin ligand (SOM230) regulates human and rat anterior pituitary hormonesecretion. J Clin Endocrinol Metab. 2004 Jun;89(6):3027-32.
实验方案
- 计算器
- 储存液制备
技术信息
| CAS号 | 396091-77-3 | 储存条件 |
|
|
| 分子式 | C62H73N11O13 | 运输 | 蓝冰 | |
| 分子量 | 1180.31 | 别名 | SOM230 L-aspartate;Pasireotide L-Aspartate Salt;帕瑞肽天门冬氨酸盐 |
